OptimizeRx Corporation (OPRX)

NASDAQ: OPRX · Real-Time Price · USD

9.66

0.54 (5.92%)

At close: May 01, 2025, 3:58 PM

5.92% (1D)

Bid	9.65
Market Cap	178.71M
Revenue (ttm)	92.13M
Net Income (ttm)	-20.11M
EPS (ttm)	-1.1
PE Ratio (ttm)	-8.79
Forward PE	15.52
Analyst	Buy

Ask	9.67
Volume	235,749
Avg. Volume (20D)	521,845
Open	9.13
Previous Close	9.12
Day's Range	8.94 - 9.90
52-Week Range	3.78 - 14.13
Beta	1.18

About OPRX

OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support mes...

Sector Healthcare

IPO Date Nov 28, 2007

Employees 128

Stock Exchange NASDAQ

Ticker Symbol OPRX

Website https://www.optimizerx.com

Full Company Profile

Analyst Forecast

According to 8 analyst ratings, the average rating for OPRX stock is "Buy." The 12-month stock price forecast is $8, which is a decrease of -17.23% from the latest price.

Stock Forecasts

Next Earnings Release

OptimizeRx Corporation is scheduled to release its earnings on May 12, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 month ago

+51.69%

OptimizeRx shares are trading higher after the com... Unlock content with Pro Subscription

3 months ago

-7.04%

OptimizeRx shares are trading lower after RBC Capital downgraded the stock from Outperform to Sector Perform and cut its price target from $7 to $6.

News

1 month ago · benzinga.com

OptimizeRx Clocks Double-Digit Revenue Growth In Q4, Forecasts Sales Of At Least $100 Million

OPTIMIZERx Corp. OPRX, a health care technology firm, reported on Wednesday fourth-quarter sales of $32.32 million, up 14% year-over-year, beating the consensus of $30.36 million.

1 month ago · seekingalpha.com

OptimizeRx Corporation (OPRX) Q4 2024 Earnings Call Transcript

OptimizeRx Corporation (NASDAQ:OPRX ) Q4 2024 Results Conference Call March 12, 2025 8:30 AM ET Company Participants Steve Silvestro - President Edward Stelmakh - Chief Financial Officer and Chief Ope...

1 month ago · zacks.com

OptimizeRx Corp. (OPRX) Q4 Earnings and Revenues Beat Estimates

OptimizeRx Corp. (OPRX) came out with quarterly earnings of $0.30 per share, beating the Zacks Consensus Estimate of $0.25 per share. This compares to earnings of $0.26 per share a year ago.